Skip to content

Industry Event

DIA US 2015

The DIA 2015 51st Annual Meeting is the largest multidisciplinary event that brings together a community of life sciences professionals at all levels and across all disciplines, who come together with the common goal of fostering innovation that will lead to the development of safe and effective medical products and therapies for patients everywhere.

Monday, June 15, 2015 @ 8:30am

Clinical Quality Management Systems in the New Millennium

Chair: Deborah Driscoll, MS, Vice President, Quality Assurance, Medical Division, Pfizer Inc.

FDA Perspective: Jean M. Mulinde, MD, Acting Senior Advisor, Division of GCP Compliance, OSI, CDER, FDA

Industry Persepctive: Ann Meeker-O’Connell, MS, Head, Risk Management and External Engagement, Bioresearch Quality & Compliance, Janssen Pharmaceuticals, Inc.

Issue Management: Leslie M. Sam, Director, Global Quality Systems, Eli Lilly and Company Quality Management Systems in the New Millennium#sthash.2pcVqQXI.dpuf


Wednesday, June 17 @ 10:30am

Putting It All Together: A Shared, Comprehensive, Integrated Global System for Clinical Research

Briggs W. Morrison, MD, Head, Global Medicines Department, AstraZeneca Pharmaceuticals, LP (panelist),%20Comprehensive,%20Integrated%20Global


Wednesday, June 17 @ 1:30pm

TransCelerate Collaboration: Harmonization Efforts to Find Solutions to Critical Industry Challenges

Andy Lee, VP, Head of Global Clinical Trial Operations at Merck & Co./ TransCelerate Operations Committee and Corporate Treasurer

Jackie Kent, Senior Director, Clinical Development Information & Optimization (CDIO) Eli Lilly/TransCelerate Shared Investigator Platform Leader

Brett Wilson, Senior Director, BMS/TransCelerate Leader

Edward Bowen, Senior Director, Translational and Bioinformatics, Pfizer/TransCelerate Placebo Leader

Robert DiCicco, Vice President, Clinical Pharmacology Sciences and Study Operations, Glaxo SmithKline/TransCelerate Common Protocol Template Leader


Wednesday, June 17 @ 3:30pm

TransCelerate’s Data Integrity and GCP Misconduct Detection Best Practice Recommendations for Clinical Statisticians in the Context of RBM

Yodit Seifu, PhD, Senior Manager II, Allergen, Inc.